Priority Date: 19.03.12 (US 201261612550P)

GROWTH DIFFERENTIATION FACTOR (GDF) FOR TREATMENT OF DIASTOLIC HEART FAILURE

  • Application ID: EP13764561
  • Status: EXAMINATION IN PROGRESS

Applicants

Research organisation logo small
Research Organisation

Attorney

operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Mewburn Ellis LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 19.03.2012 - Priority Date (US 201261612550P)
  • 26.09.2013 - Publication A1 (WO2013142114)
  • 28.01.2015 - Publication A1 (EP2828289)

IPC Classification